Literature DB >> 647163

Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum.

I M Coupar.   

Abstract

1 Anesthetized rats (225 to 300 g) were used to study the inhibitory effect of morphine on fluid secreted by the small intestine. 2 Small intestinal fluid secretion was stimulated by infusion of prostaglandin E1 (PGE1) into the aortic arch, the jejunum being more sensitive than the ileum. Infusion of PGE1 2 microgram/min caused maximal net fluid secretion in the jejunum but inhibited net fluid absorption in the ileum. 3 Morphine caused a dose-related inhibition of maximal PGE1-stimulated fluid secretion in the jejunum. At the higher doses of morphine used (5 to 20 mg/kg) the fluid transporting function of the jejunum was restored almost to normal net absorption. 4 The inhibitory effect of morphine on PGE1-stimulated fluid secretion was antagonized by naloxone. Naloxone caused a parallel shift to the right of the dose-response curve for morphine. 5 Two other narcotic analgesics were assayed relative to morphine and their descending order of potency was oxymorphone greater than morphine greater than pethidine. 6 It is suggested that the antisecretory effect of morphine in the small intestine may contribute to its efficacy as an anti-diarrhoeal drug. Further studies on the rat jejunum may show it to be a useful model for predicting narcotic drug activity and as such, may give some insight into the mechanisms of action of these drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647163      PMCID: PMC1668301          DOI: 10.1111/j.1476-5381.1978.tb07774.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Effects of morphine and other drugs on motility of the terminal ileum.

Authors:  E E DANIEL; W H SUTHERLAND; A BOGOCH
Journal:  Gastroenterology       Date:  1959-04       Impact factor: 22.682

2.  The action of morphine, pethidine, and amidone upon the intestinal motility of conscious dogs.

Authors:  E M V WILLAMS; D H P STREETEN
Journal:  Br J Pharmacol Chemother       Date:  1950-12

3.  Effects of narcotic analgesic drugs on the cyclic adenosine 3',5'-monophosphate-adenylate cyclase system in rat brain.

Authors:  D H Clouet; G J Gold; K Iwatsubo
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

4.  Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate.

Authors:  H O Collier; A C Roy
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

5.  Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea.

Authors:  E D Williams; S M Karim; M Sandler
Journal:  Lancet       Date:  1968-01-06       Impact factor: 79.321

6.  Prostaglandins reverse inhibition of electrically-induced contractions of guinea pig ileum by morphine, indomethacin and acetylsalicylic acid.

Authors:  S Ehrenpreis; J Greenberg; S Belman
Journal:  Nat New Biol       Date:  1973-10-31

7.  Stimulation of sodium and water secretion without inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP).

Authors:  I M Coupar
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Nov-Dec       Impact factor: 2.557

8.  Effect of serotonin treatment on intestinal transport in the rabbit.

Authors:  M Donowitz; A N Charney; J M Heffernan
Journal:  Am J Physiol       Date:  1977-01

9.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

10.  Acute effects of morphine on rat intestinal motility.

Authors:  T F Burks
Journal:  Eur J Pharmacol       Date:  1976-12       Impact factor: 4.432

View more
  13 in total

1.  Voltage-clamp experiments reveal receptor type-dependent modulation of chloride secretion in the guinea pig colonic mucosa by intestinal opioids.

Authors:  W Kromer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

2.  Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.

Authors:  K J Moriarty; D D Rolston; M J Kelly; M Shield; M L Clark
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

3.  Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists.

Authors:  E Beubler; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

4.  Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum.

Authors:  E Beubler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

5.  Effects of bombesin, calcitonin, and enkephalin on canine jejunal water and electrolyte transport.

Authors:  G O Barbezat; P G Reasbeck
Journal:  Dig Dis Sci       Date:  1983-03       Impact factor: 3.199

6.  Characterization of the opiate receptor population mediating inhibition of VIP-induced secretion from the small intestine of the rat.

Authors:  I M Coupar
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

7.  The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat.

Authors:  J Hardcastle; P T Hardcastle; N W Read; J S Redfern
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

8.  Inhibition of PGE1 induced intestinal secretion by the synthetic enkephalin analogue FK 33-824.

Authors:  F Lembeck; E Beubler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

9.  Inhibitory actions of loperamide on absorptive processes in rat small intestine.

Authors:  J Hardcastle; P T Hardcastle; J Cookson
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

10.  Inhibition by morphine of prostaglandin E1-stimulated secretion and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum in vivo.

Authors:  E Beubler; F Lembeck
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.